Farmaceutisk kemi og teknologi
Se alle bogdetaljer →
Generic Drug Product Development
International Regulatory Requirements for Bioequivalence
Udgivet af Taylor & Francis Ltd
ISBN
9780367384371
Om denne bog
Due to a worldwide need for lower cost drug therapy, use of generic and multi-source drug products have been increasing. To meet international patent and trade agreements, the development and sale of these products must conform to national and international laws, and generic products must prove that they are of the sam…
Boghandelspriser
| Boghandel | Titel | Format | ISBN | Pris | Lagerstatus | Levering | |
|---|---|---|---|---|---|---|---|
Ingen boghandelstilbud endnuVi har titlen i kataloget. Priser vises her, når boghandlere lister den. |
|||||||
5
0
4
0
3
0
2
0
1
0
0%
Anbefaler
0
Verificeret
Ingen anmeldelser endnu
Bogdetaljer
Forlag
Taylor & Francis Ltd
Kategori
Farmaceutisk kemi og teknologi
ISBN-13
9780367384371
EAN
9780367384371
Format
Hæftet
Sprog
Engelsk
sider
332
Undertitel
- International Regulatory Requirements for Bioequivalence
Produktbeskrivelse
Due to a worldwide need for lower cost drug therapy, use of generic and multi-source drug products have been increasing. To meet international patent and trade agreements, the development and sale of these products must conform to national and international laws, and generic products must prove that they are of the same quality and are therapeutically equivalent to the brand name alternative. However, many countries have limited resources to inspect and verify the quality of all drug products for sale in their country. This title discusses the worldwide legislative and regulatory requirements for the registration of generic and multi-source drug products.
Prishistorik
Indlæser prishistorik...